Investigating Black‐White differences in prostate cancer prognosis: A systematic review and meta‐analysis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Cancer

• Publication date

  2008-07-15

• Fields of study

  Medicine, Sociology

• Identifiers
  DOI 10.1002/ijc.23500PMID 18452170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [EAU guidelines on prostate cancer].

  2009cited by this paper
• Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004.

  2007cited by this paper
• Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey

  2007cited by this paper
• The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study.

  2007cited by this paper
• Racial Differences in Clinical Progression Among Medicare Recipients After Treatment for Localized Prostate Cancer (United States)

  2006cited by this paper
• Who is at greatest risk for receiving poor-quality health care?

  2006cited by this paper
• Who is at greatest risk for receiving poor-quality health care?

  2006cited by this paper
• Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma

  2006cited by this paper
• Explaining racial differences in prostate cancer in the United States: Sociology or biology?

  2005cited by this paper
• Radical prostatectomy versus watchful waiting in early prostate cancer.

  2005cited by this paper
• Racial Differences in Prostate Cancer Treatment Outcomes: A Systematic Review

  2005cited by this paper
• Geographic and socioeconomic variation in the treatment of prostate cancer.

  2005cited by this paper
• Racial treatment trends in localized/regional prostate carcinoma: 1992–1999

  2005cited by this paper
• Radical prostatectomy versus watchful waiting in early prostate cancer.

  2005cited by this paper
• Unequal Treatment—Confronting Racial and Ethnic Disparities in Healthcare

  2004cited by this paper
• Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

  2004cited by this paper
• Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer

  2004cited by this paper
• Racial Differences in Initial Treatment for Clinically Localized Prostate Cancer. Results From the Prostate Cancer Outcomes Study

  2004cited by this paper
• Race/Ethnicity and the Intensity of Medical Monitoring Under ‘Watchful Waiting’ for Prostate Cancer

  2004cited by this paper
• Racial differences in screening for prostate cancer in the elderly.

  2004cited by this paper
• Racial/ethnic disparities in the treatment of localized/regional prostate cancer.

  2004cited by this paper
• Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

  2004cited by this paper
• Screen‐detected prostate cancer and the insulin‐like growth factor axis: Results of a population‐based case‐control study

  2004cited by this paper
• Racial differences in initial treatment for clinically localized prostate cancer

  2003cited by this paper
• Prostate cancer in Black and White men: are there differences in risk or prognosis?

  2003cited by this paper
• Survival of blacks and whites after a cancer diagnosis.

  2002cited by this paper
• Racial and ethnic disparities in the receipt of cancer treatment.

  2002cited by this paper
• Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

  2002cited by this paper
• Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

  2002cited by this paper
• Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

  2002cited by this paper
• EAU guidelines on prostate cancer.

  2001cited by this paper
• Epidemiology of the insulin-like growth factor system in three ethnic groups.

  2001cited by this paper
• The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States

  1998cited by this paper
• Trends and black/white differences in treatment for nonmetastatic prostate cancer.

  1998cited by this paper
• Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

  1998cited by this paper
• Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial.

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.

  1995cited by this paper
• The “Working Group”

  1994cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Explaining Racial Differences

  1983cited by this paper

• Burden of prostate cancer in older adults, 1990–2021: a systematic analysis based on the global burden of disease study 2021

  2026cites this paper
• Inflammatory status of periprostatic adipose tissue from men with prostate cancer: Ethno-geographic variations and association with lipid composition.

  2025cites this paper
• Development and validation of a machine learning-based risk model for metastatic disease in nmCRPC patients: a tumor marker prognostic study

  2025cites this paper
• Ethnic and Socio-Economic Variations in Comorbidity and Mortality in Cancer Survivors: A UK Population-Based Observational Study

  2025cites this paper
• The Man Van: A pilot study of using mobile targeted case‐finding to address health inequalities in prostate cancer

  2024cites this paper
• Investigating racial differences in mortality and survival outcomes following radical prostatectomy: a systematic review and meta-analysis

  2024cites this paper
• A review of dairy food intake for improving health among black adults in the US.

  2024cites this paper
• The Lancet Commission on prostate cancer: planning for the surge in cases

  2024cites this paper
• Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.

  2024cites this paper
• Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms

  2023cites this paper
• Symptom appraisal and help seeking in males with symptoms of possible prostate cancer: a qualitative study with an ethnically diverse sample in London

  2023cites this paper
• Prostate cancer among South Asian men in the United Kingdom: A systematic review

  2023cites this paper
• Prostate Cancer Disparities in Metastatic and Treatment Status for Hispanic Americans Based on Country of Origin Compared to Non-Hispanic Whites Using the National Cancer Database.

  2023cites this paper
• Black men's experiences of support following treatment for prostate cancer in England: A qualitative study.

  2022cites this paper
• Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review

  2022cites this paper
• Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario

  2022cites this paper
• Betulinic acid and its ionic derivatives impaired growth of prostate cancer cells without induction of GRP78 and CHOP

  2022cites this paper
• Alcohol dehydrogenase expression patterns in normal prostate, benign prostatic hyperplasia, and prostatic adenocarcinoma in African American and Caucasian men

  2022cites this paper
• Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA

  2022cites this paper
• MicroRNA-mRNA Regulatory Network Mediates Activation of mTOR and VEGF Signaling in African American Prostate Cancer

  2022cites this paper
• Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review

  2022cites this paper
• Persistent organochlorine pesticides in periprostatic adipose tissue from men with prostate cancer: Ethno-geographic variations, association with disease aggressiveness.

  2022cites this paper
• Primary care use by men with symptoms of possible prostate cancer: A multi-method study with an ethnically diverse sample in London.

  2021influential citation
• Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England

  2021cites this paper
• Prevalence and Demographic Characteristics of Prostate Cancer Patients in Colombia: data from the National Health Registry from 2015 to 2019

  2021cites this paper
• An Integrative Counseling Approach for African American Couples With Prostate Cancer

  2021cites this paper
• Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database

  2021cites this paper
• Tissue cholesterol metabolism and prostate cancer aggressiveness: Ethno‐geographic variations

  2021cites this paper
• Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre

  2021cites this paper
• Cancer Progress and Priorities: Prostate Cancer

  2020cites this paper
• Black men and prostate cancer in the UK

  2020cites this paper
• Black African and black Caribbean men’s understanding and experiences of prostate cancer post-treatment in England: a qualitative study

  2020cites this paper
• The Molecular Mechanisms Underlying the Cancer Killing Effect of Interleukin-24

  2019cites this paper
• Role of Alternative Splicing in Prostate Cancer Aggressiveness and Drug Resistance in African Americans.

  2019cites this paper
• MicroRNA-4719 and microRNA-6756-5p Correlate with Castration-Resistant Prostate Cancer Progression through Interleukin-24 Regulation

  2019cites this paper
• African-American Prostate Normal and Cancer Cells for Health Disparities Research.

  2019cites this paper
• Hunter College 12-22-2015 PVT 1 Exon 9 : A Potential Biomarker of Aggressive Prostate Cancer ?

  2019cites this paper
• Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts

  2019cites this paper
• A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance

  2019cites this paper
• Rethinking active surveillance for prostate cancer in African American men

  2018cites this paper
• Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood.

  2018influential citation
• Can We Screen and Still Reduce Overdiagnosis

  2018cites this paper
• Social determinants of prostate cancer in the Caribbean: a systematic review and meta-analysis

  2018cites this paper
• Fatty acid profile in peri-prostatic adipose tissue and prostate cancer aggressiveness in African-Caribbean and Caucasian patients.

  2018influential citation
• Rare germline mutations in African American men diagnosed with early‐onset prostate cancer

  2018cites this paper
• MicroRNAs differentially expressed in prostate cancer of African-American and European-American men

  2018cites this paper
• Prostate Cancer in Primary Care

  2018cites this paper
• Impact of ethnicity on the outcome of men with metastatic, hormone‐sensitive prostate cancer

  2017influential citation
• Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.

  2017cites this paper
• Fatalism, medical mistrust, and pretreatment health‐related quality of life in ethnically diverse prostate cancer patients

  2017cites this paper
• Social Networks Across Common Cancer Types: The Evidence, Gaps, and Areas of Potential Impact.

  2017cites this paper
• Predicting Prostate Cancer Recurrence After Radical Prostatectomy

  2017cites this paper
• 68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans

  2017influential citation
• Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer

  2017cites this paper
• Cancer beliefs in ethnic minority populations: a review and meta-synthesis of qualitative studies.

  2017cites this paper
• The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.

  2017cites this paper
• Population‐Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients

  2017cites this paper
• A Nationwide Survey of Prostate Specific Antigen Based Screening and Counseling for Prostate Cancer

  2017cites this paper
• Epidemiology of Prostate and Testicular Cancer

  2016cites this paper
• Ethnicity and the prostate cancer experience: a qualitative metasynthesis

  2016cites this paper
• Screening for familial and hereditary prostate cancer

  2016cites this paper
• Utilization of surgical procedures and racial disparity in the treatment of urinary incontinence after prostatectomy

  2016cites this paper
• Prostate cancer burden in Central and South America.

  2016cites this paper
• Eradicating Health Care Disparities in the Surgical Management of ProstateCancer

  2016cites this paper
• Etiology of prostate cancer ( C 61 ) in Central and South America

  2016cites this paper
• 93 A nationwide survey of prostate specific antigen based screening and counseling for prostate cancer

  2016cites this paper
• Do Sociodemographic Factors Influence Outcome in Prostate Cancer Patients Treated With External Beam Radiation Therapy?

  2016cites this paper
• Ethnic differences in patients' preferences for prostate cancer investigation: a vignette-based survey in primary care.

  2015cites this paper
• Identification and Functional Validation of Reciprocal microRNA–mRNA Pairings in African American Prostate Cancer Disparities

  2015cites this paper
• Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010

  2015cites this paper
• Multigene panels in prostate cancer risk assessment: a systematic review

  2015cites this paper
• PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?

  2015cites this paper
• Ethnicity and prostate cancer: the way to solve the screening problem?

  2015cites this paper
• Immunohistological Analysis of ABCD3 Expression in Caucasian and African American Prostate Tumors

  2015cites this paper
• Differential splicing of oncogenes and tumor suppressor genes in African and Caucasian American populations: contributing factor in prostate cancer disparities

  2015cites this paper
• Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment.

  2015cites this paper
• Disparities in receipt of radiotherapy and survival by age, sex and ethnicity among patients with stage I diffuse large B-cell lymphoma

  2015cites this paper
• A Meta-Analysis of Association Between One-Carbon Metabolism Gene Polymorphisms and Risk of Prostate Cancer

  2015cites this paper
• Métricas en el control de calidad individualizado de técnicas volumétricas y su aplicación a la patología de próstata

  2015cites this paper
• The epidemiology and management of prostate cancer in New Zealand

  2015cites this paper
• Hormonal and genetic regulation of prostate cancer in Caucasian and Malaysian Chinese ethnic groups

  2015cites this paper
• PSA – targeting the men at highest risk

  2015cites this paper
• Update on prostate cancer in black men within the UK

  2014cites this paper
• 8q24 risk alleles and prostate cancer in African‐Barbadian men

  2014cites this paper
• Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up.

  2014cites this paper
• The prognostic significance of perineural invasion and race in men considering active surveillance

  2014cites this paper
• Prostate Cancer as a Metabolic Disease - Is Prostate Cancer Diagnosis Associated with Worse Cardiovascular Outcomes?

  2014cites this paper
• Surgical Quality IsMore Than Volume: The Association between Changing Urologists and Complications for Patients with Localized Prostate Cancer

  2014cites this paper
• Active surveillance of prostate cancer in African American men.

  2014cites this paper
• 2 IntegratedCancerGenomicsDivision,TranslationalGenomicsResearchInstitute(TGen),Phoenix,Arizona 3 DepartmentofPreventiveMedicine,KeckSchoolofMedicine,UniversityofSouthernCalifornia,

  2014cites this paper
• Surgical quality is more than volume: the association between changing urologists and complications for patients with localized prostate cancer.

  2014cites this paper
• Impact of Obesity, Race, and Ethnicity on Cancer Survivorship

  2014cites this paper
• Prostate cancer disease characteristics for foreign-born South Asian men living in the United States.

  2013cites this paper
• Sociodemographic and Clinical Factors Associated with the Diagnosis, Initial Treatment Selection and Survival of Prostate Cancer in Florida

  2013cites this paper
• Characterization of Perioperative Leukocytosis in Patients Undergoing Robot-Assisted Radical Prostatectomy: Effects of Gleason Score and Race

  2013cites this paper
• Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010

  2013cites this paper
• Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort

  2013cites this paper
• Racial Disparities and the Global Picture

  2013cites this paper
• Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data.

  2013cites this paper
• The Role of Prostatitis in Prostate Cancer: Meta-Analysis

  2013cites this paper